Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp (BLCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
5 Revealing Analyst Questions From Bausch + Lomb’s Q4 Earnings Call

5 Revealing Analyst Questions From Bausch + Lomb’s Q4 Earnings Call

BLCO : 17.93 (-0.28%)
Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®

Global review highlights increasing prevalence of noninfectious ocular redness due to digital eye strain, dry eye disease, allergies and environmental exposures LUMIFY redness reliever...

BLCO.TO : 24.54 (+0.70%)
BLCO : 17.93 (-0.28%)
3 Small-Cap Stocks We Steer Clear Of

3 Small-Cap Stocks We Steer Clear Of

BLCO : 17.93 (-0.28%)
NVAX : 9.68 (+2.00%)
VNT : 40.70 (+0.89%)
BLCO Q4 2025 Deep Dive: Dry Eye and Product Innovation Propel Growth, Margin Expansion in Focus

BLCO Q4 2025 Deep Dive: Dry Eye and Product Innovation Propel Growth, Margin Expansion in Focus

BLCO : 17.93 (-0.28%)
Bausch + Lomb’s (NYSE:BLCO) Q4 CY2025: Beats On Revenue

Bausch + Lomb’s (NYSE:BLCO) Q4 CY2025: Beats On Revenue

BLCO : 17.93 (-0.28%)
Bausch + Lomb: Q4 Earnings Snapshot

Bausch + Lomb: Q4 Earnings Snapshot

BLCO : 17.93 (-0.28%)
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance

Delivered meaningful EBITDA margin expansion and operating leverage in the fourth quarter Fourth-Quarter 2025 Financial Results ...

BLCO.TO : 24.54 (+0.70%)
BLCO : 17.93 (-0.28%)
Bausch + Lomb (BLCO) Q4 Earnings: What To Expect

Bausch + Lomb (BLCO) Q4 Earnings: What To Expect

BLCO : 17.93 (-0.28%)
3 Reasons to Sell BLCO and 1 Stock to Buy Instead

3 Reasons to Sell BLCO and 1 Stock to Buy Instead

BLCO : 17.93 (-0.28%)
1 Healthcare Stock to Research Further and 2 Facing Headwinds

1 Healthcare Stock to Research Further and 2 Facing Headwinds

HIMS : 16.38 (+3.54%)
BLCO : 17.93 (-0.28%)
CNC : 44.99 (+2.67%)

Barchart Exclusives

Amazon Stock: Rebound Ahead or Prolonged Bearish Pressure in 2026?
Despite the challenges, Amazon’s fundamentals remain solid, supported by accelerating cloud and advertising performance and fast-growing chips business. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar